# [68Ga]Ga-FAPI-46 PET/CT in Ovarian Cancer

> **NCT05903807** · PHASE2 · RECRUITING · sponsor: **Aalborg University Hospital** · enrollment: 50 (estimated)

## Conditions studied

- Ovarian Cancer

## Interventions

- **DRUG:** 68Ga-FAPi-46

## Key facts

- **NCT ID:** NCT05903807
- **Lead sponsor:** Aalborg University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-11-17
- **Primary completion:** 2026-12-01
- **Final completion:** 2035-01-01
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2025-01-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05903807

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05903807, "[68Ga]Ga-FAPI-46 PET/CT in Ovarian Cancer". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05903807. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*